Colomer Bosch, Ramon ramon.colomer@uam.es

Publications

3D Assessment of Lymph Nodes vs. RECIST 1.1

  • Steger, Sebastian
  • Franco, Fabio
  • Sverzellati, Nicola
  • Chiari, Gianfranco
  • Colomer, Ramon;

Academic Radiology (p. 391-394) - 1/3/2011

10.1016/j.acra.2010.11.010 View at source

  • ISSN 10766332

MYELIN BASIC-PROTEIN AND CREATINE-KINASE BB ISOENZYME AS CSF MARKERS OF INTRACRANIAL TUMORS AND STROKE

  • MATIASGUIU, J
  • MARTINEZVAZQUEZ, J
  • RUIBAL, A
  • COLOMER, R
  • BOADA, M
  • CODINA, A;

Acta Neurologica Scandinavica (p. 461-465) - 1/1/1986

10.1111/j.1600-0404.1986.tb04585.x View at source

  • ISSN 00016314

CRANIAL CT-SCAN IN TRANSIENT GLOBAL AMNESIA

  • Matias-Guiu J, Colomer R, Segura A, Codina A

Acta Neurologica Scandinavica (p. 298-301) - 1/1/1986

10.1111/j.1600-0404.1986.tb03280.x View at source

  • ISSN 00016314

Gemcitabine in combination with paclitaxel in the first-line treatment of metastatic breast cancer

  • Delfino C
  • Colomer R

American Journal Of Cancer (p. 334-335) - 1/1/2005

10.2165/00024669-200504050-00009 View at source

  • ISSN 11756357

Dose and dose intensity effect of adjuvant anthracycline-based chemotherapy in early breast cancer - A retrospective analysis

  • Maria L Amador
  • Antonio Jimeno
  • Ricardo Hitt
  • Hernán Cortés-Funes
  • Rámón Colomer

American Journal Of Clinical Oncology-Cancer Clinical Trials (p. 269-273) - 1/6/2004

10.1097/01.coc.0000093082.79608.1a View at source

  • ISSN 02773732

A FREQUENT TYROSINASE GENE MUTATION ASSOCIATED WITH TYPE I-A (TYROSINASE-NEGATIVE) OCULOCUTANEOUS ALBINISM IN PUERTO-RICO

  • OETTING, WS
  • WITKOP, CJ
  • BROWN, SA
  • COLOMER, R
  • FRYER, JP
  • BLOOM, KE
  • KING, RA;
... View more Collapse

American Journal Of Human Genetics (p. 17-23) - 1/1/1993

  • ISSN 00029297
  • iMarina

Els assaigs clínics en Oncologia

  • Ramón Colomer Bosch

Annals De Medicina (p. 104-106) - 1/1/2004

  • ISSN 02107465
  • iMarina

Treatment of cancer with oral drugs: A position statement by the Spanish Society of Medical Oncology (SEOM)

  • R Colomer
  • E Alba
  • A González-Martin
  • L Paz-Ares
  • M Martín
  • A Llombart
  • A Rodríguez Lescure
  • J Salvador
  • J Albanell
  • D Isla
  • M Lomas
  • CA Rodríguez
  • JM Trigo
  • JR Germà
  • J Bellmunt
  • J Tabernero
  • R Rosell
  • E Aranda
  • R Cubedo
  • J Baselga
  • Spanish Society of Medical Oncology
... View more Collapse

Annals Of Oncology (p. 195-198) - 1/1/2010

10.1093/annonc/mdp595 View at source

  • ISSN 09237534

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study

  • Swain, S. M.
  • Ewer, M. S.
  • Viale, G.
  • Delaloge, S.
  • Ferrero, J-M
  • Verrill, M.
  • Colomer, R.
  • Vieira, C.
  • Werner, T. L.
  • Douthwaite, H.
  • Bradley, D.
  • Waldron-Lynch, M.
  • Kiermaier, A.
  • Eng-Wong, J.
  • Dang, C.;BERENICE Study Grp
... View more Collapse

Annals Of Oncology (p. 646-653) - 1/3/2018

10.1093/annonc/mdx773 View at source

  • ISSN 09237534

Dietary fatty acids regulate the activation status of Her-2/neu (c-erb B-2) oncogene in breast cancer cells

  • Menendez, J.A.
  • Ropero, S.
  • Lupu, R.
  • Colomer, R.

Annals Of Oncology (p. 1719-1721) - 1/1/2004

Editor: Oxford University Press

10.1093/annonc/mdh442 View at source

  • ISSN 09237534
  • ISSN/ISBN 0923-7534

Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …

  • Chau Dang
  • Michael S Ewer
  • Suzette Delaloge
  • Jean-Marc Ferrero
  • Mark Verrill
  • Ramon Colomer
  • Claudia Vieira
  • Luis de la Cruz Merino
  • Jennifer Lucas
  • Theresa L Werner
  • Hannah Douthwaite
  • Denise Bradley
  • Maeve Waldron-Lynch
  • Jennifer Eng-Wong
  • Sandra M Swain
... View more Collapse

1/1/2018

  • iMarina

Tratado de oncología

  • Hernán Cortés-Funes
  • Ramón Colomer Bosch
  • Emilio Alba Conejo

1/1/2009

  • ISBN 9788492620166
  • iMarina

Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  • J Rogado
  • MD Fenor De La Maza
  • V Pacheco-Barcia
  • JM Serra
  • P Toquero
  • B Vera
  • A Ballesteros
  • R Mondejar
  • O Donnay
  • B Obispo
  • R Colomer
  • JM Sanchez-Torres
... View more Collapse

1/1/2017

  • iMarina

Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study

  • J Albanell
  • E Ciruelos
  • R Colomer
  • J De la Haba
  • M Martin
  • De Salas-Cansado
  • B Munoz-Molina
  • C Tournier
  • P Thuresson
  • W Schleich
... View more Collapse

1/1/2015

  • iMarina

Medicina de precisión en oncología: Éxitos y perspectivas bioéticas

  • Ramón Colomer Bosch

Bioética Y Cáncer (p. 17-26) - 1/1/2020

  • iMarina

Fatty acid metabolism in cancer cell survival: A new anti-cancer target

  • Porta, Rut
  • Colomer, Ramon
  • Puig, Teresa;

Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011

  • iMarina

Tratamiento hormonal del cáncer

  • Ramón Colomer Bosch
  • M L Amador
  • J González Cortijo
  • MV Tornamira

Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003

  • iMarina

Circulating angiogenic growth factors as predictive factors in metastatic breast cancer treated with letrozole.

  • Alba E
  • Gonzalez F
  • Llombart A
  • Ramos M
  • Mayordomo J
  • Fernandez R
  • Tusquets I
  • Barnadas A
  • Gil M
  • Carabantes F
  • Baena J
  • Ruiz M
  • Palomero M
  • Vera R
  • Munoz M
  • Constenla M
  • Rifa J
  • Ojeda B
  • Calvo L
  • Lloveras B
  • Colomer R
... View more Collapse

Breast Cancer Research And Treatment (p. 244-244) - 1/1/2001

  • ISSN 01676806
  • iMarina

HER2 ECD-positive metastatic breast cancer treated with gemcitabine, paclitaxel plus trastuzumab (GTH)

  • R Colomer
  • J Mayordomo
  • L Calvo
  • J Horned'o
  • F Carabantes
  • M Gil
  • H Cortes-Funes
  • B Martin
... View more Collapse

Breast Cancer Research And Treatment (p. S127-S128) - 1/1/2004

  • ISSN 01676806
  • iMarina

Pharmacological and small interference RNA-induced inhibition of the lipogenic enzyme fatty acid synthase synergistically enhances Taxol (TM) (paclitaxel)-induced apoptotic breast cancer cell death

  • Menendez, JA
  • Vellon, L
  • Colomer, R
  • Lupu, R;

Breast Cancer Research And Treatment (p. S32-S32) - 1/1/2004

  • ISSN 01676806
  • iMarina

Fatty acid synthase (FAS)-catalyzed endogenous fatty acid metabolism regulates Her-2/neu (erbB-2) oncogene expression via malonyl-coenzyme-a-dependent expression of the Ets protein polyomavirus enhancer activator 3 (PEA3), a transcriptional repressor of Her-2/neu promoter activity in cancer cells.

  • Menendez, JA
  • Papadimitropoulou, A
  • Vellon, L
  • Colomer, R
  • Lupu, R;

Breast Cancer Research And Treatment (p. S183-S183) - 1/1/2005

  • ISSN 01676806
  • iMarina

Gemcitabine plus Paclitaxel, is there a better schedule for treatment?

  • C Oliveras
  • A Vázquez-Martin
  • L Ferrer
  • R de Llorens
  • R Colomer

Breast Cancer Research And Treatment (p. S205-S205) - 1/1/2004

  • ISSN 01676806
  • iMarina

Serum HER-2 ECD and the efficacy of letrozole in ER+/PR+ metastatic breast cancer: preliminary results of a prospective study.

  • Colomer R., Llombart A., Ramos M., Mayordomo J., Fernandez R., Tusquets I., Barnadas A., Gil M., Carabantes F., Baena J., Ruiz M., Palomero M., Vera R., Munoz M., Constenla M., Rita J., Ojeda B., Calvo L., Lloveras B., Montero S., Alba E.

Breast Cancer Research And Treatment (p. 242-242) - 1/1/2001

  • ISSN 01676806
  • iMarina

Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study

  • Quintela-Fandino, M.
  • Urruticoechea, A.
  • Guerra, J.
  • Gil, M.
  • Gonzalez-Martin, A.
  • Marquez, R.
  • Hernandez-Agudo, E.
  • Rodriguez-Martin, C.
  • Gil, M.
  • Bratos, R.
  • Escudero, M. J.
  • Colomer, R.;
... View more Collapse

Cancer Research - 15/12/2013

10.1158/0008-5472.sabcs13-pd5-8 View at source

  • ISSN 00085472

The BOMET-QOL questionnaire in patients with breast cancer and bone metastasis: The prospective MABOMET study from the Spanish breast cancer research group (GEICAM)

  • Del Barco, S.
  • Munoz, M.
  • Margeli, M.
  • Chacon, Ji
  • Cassinello, J.
  • Antolin, S.
  • Adrover, E.
  • Ramos-Vazquez, M.
  • Carrasco, E.
  • Jimeno, M. A.
  • Ojeda, B.
  • Gonzalez, X.
  • Gonzalez, S.
  • Constenla, M.
  • Florian, J.
  • Miguel, A.
  • Llombart, A.
  • Lluch, A.
  • Ruiz-Borrego, M.
  • Colomer, R.
  • Barnadas, A.;
... View more Collapse

Cancer Research - 1/1/2013

10.1158/0008-5472.sabcs13-p3-10-02 View at source

  • ISSN 00085472

18F-misonidazole PET (FMISO-PET) monitors vascular normalization (VN) and predicts benefit from antiangiogenic treatment plus chemotherapy in pancreas cancer

  • Mondejar, Tamara
  • Hernadez-Agudo, Elena
  • Soto-Montenegro, Marisa
  • Megias, Diego
  • Cebrian, David
  • Sanchez, Jesus
  • Mulero, Francisca
  • Colomer, Ramon
  • Hidalgo, Manuel
  • Desco, Manuel
  • Quintela-Fandino, Miguel;
... View more Collapse

Cancer Research - 1/1/2015

10.1158/1538-7445.am2015-1493 View at source

  • ISSN 00085472

Estimating costs of relapsing HER2+breast cancer in Spain

  • Colomer, R.
  • Ciruelos, E.
  • De la Haba, J.
  • Martin, M.
  • De Salas-Cansado, M.
  • Munoz-Molina, B.
  • Albanell, J.;
... View more Collapse

Cancer Research - 1/1/2017

10.1158/1538-7445.sabcs16-p3-12-05 View at source

  • ISSN 00085472

[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]

  • Sanchez-Munoz, A
  • Gravalos Castro, C
  • Colomer Bosch, R
  • Garcia Velasco, A
  • Garcia, J P
  • Cortes-Funes, H

Revista Clinica Espanola (p. 597-598) - 1/1/2003

10.1157/13053731

  • ISSN 15781860
  • iMarina

A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer

  • Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R

Clinical Breast Cancer (p. 286-91) - 1/1/2003

10.3816/cbc.2003.n.034 View at source

  • ISSN 15268209

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

  • Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators

Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020

10.1200/jco.20.02514

  • ISSN 0732183X
  • iMarina

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization

  • Arranz, R.
  • García-Alfonso, P.
  • Sobrino, P.
  • Zamora, P.
  • Carrión, R.
  • García-Laraña, J.
  • Pérez, G.
  • López, J.
  • Lavilla, E.
  • Lozano, M.
  • Rayón, C.
  • Colomer, R.
  • González Barón, M.
  • Flores, E.
  • Pérez-Manga, G.
  • Fernández-Rañada, J.M.
... View more Collapse

Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998

Editor: American Society of Clinical Oncology

10.1200/jco.1998.16.4.1538 View at source

  • ISSN 0732183X
  • ISSN/ISBN 0732-183X

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.

  • Hitt, R
  • Paz-Ares, L
  • Hidalgo, M
  • Colomer, R
  • Brandariz, A
  • Pena, M
  • Alvarez-Vicent, J
  • Hornedo, J
  • Cortes-Funes, H;
... View more Collapse

Seminars In Oncology (p. S19-20) - 1/12/1997

  • ISSN 00937754
  • iMarina

Desestabilización estructural de la adicción a oncogenes en cáncer de mama mediante el bloqueo de la sintasa de ácidos grasos

  • Colomer Bosch, Ramon (Investigador principal (IP))

Period: 01-01-2012 - 31-12-2014

  • iMarina

Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas

  • Rebeca Mondéjar Solís (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia

28/1/2021

  • iMarina

Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís

1/1/2016

  • iMarina

El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Javier Abel Menéndez Menéndez (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo

1/1/2016

  • iMarina

Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín

1/1/2007

  • iMarina

Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia

1/1/2004

  • iMarina

Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo

1/1/2003

  • iMarina

Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz

1/1/2002

  • iMarina

Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez

1/1/2001

  • iMarina

Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater

1/1/1996

  • iMarina

This researcher has no patents or software licenses.

Last data update: 4/24/24 1:20 PM